Last reviewed · How we verify
Pneumonia due to Escherichia coli
Approved treatments
- MEZLOCILLIN
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Tobi · Novartis
- Claforan · Sterimax
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - ALATROFLOXACIN · Pfizer
- Nebcin · University Hospital, Lille
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Monocid
- Teflaro · AbbVie
Teflaro works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Cefotan
- Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - AZLOCILLIN · Bayer Pharmaceuticals Corp
- TICARCILLIN
- Ticarcillin
- Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Epocelin
- Zefazone
- Cipro · Bayer AG
- Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pneumonia due to Escherichia coli patent landscape — cliff calendar, originator estates, attackable patents
- Pneumonia due to Escherichia coli treatment landscape brief
- Pneumonia due to Escherichia coli treatment updates RSS
Frequently asked questions about Pneumonia due to Escherichia coli
What drugs treat Pneumonia due to Escherichia coli?
Tracked treatments include MEZLOCILLIN, Ramycin, Garamycin, Tobi, Claforan, Pipracil, Ciprofloxacine, Vantobra.
What is the treatment for Pneumonia due to Escherichia coli?
Standard treatment for Pneumonia due to Escherichia coli includes MEZLOCILLIN, Ramycin, Garamycin, Tobi, Claforan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pneumonia due to Escherichia coli patent cliff · Pneumonia due to Escherichia coli CI report
- Treatment: MEZLOCILLIN
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Tobi · Novartis
- Treatment: Claforan · Sterimax
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing